|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||28.25 / 37.19|
Investors may want to look at some small-cap pharma names that could be takeover targets like Relypsa.
Following Galenica's $1.5 billion bid for Relypsa, investors are beginning to search for the next target.
Pfizer Inc. (NYSE: PFE) announced today that the World Health Organization (WHO) has prequalified its four-dose, multi-dose vial (MDV) presentation of Prevenar 13 ®* (pneumococcal polysaccharide conjugate vaccine [13 -...
We're checking out eight companies in the portfolio that are expected to report results over the next two weeks.
At least one company follower believes the divestiture of Shire's Neurology division for as much as $13 billion would be a logical next move.
TheStreet highlights 3 stocks pushing the health care sector higher today.
The House Republicans' tax reform plan is a pretty good deal according to one analysis, especially for American corporations.
Shares in the U.K.'s leading pharmaceuticals company have risen about 20% since the June 23 Brexit vote.
Corporate governance changes are among the policy flagships unveiled by the successor to David Cameron.
Pfizer Inc. (NYSE:PFE) announced today the publication of findings from two pivotal Phase 3 studies of investigational crisaborole topical ointment 2% (formerly AN2728) in the online issue of the Journal of the American...
The FDA approved Pfizer’s (PFE) pneumonia vaccine for infants and younger adults.
Pfizer Inc. (NYSE:PFE) today announced that Prevnar 13 ® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) received U.
They need to do something that makes them stand out as stocks you want to own, not avoid.
Pfizer Inc. (NYSE:PFE) today announced that the S-TRAC clinical trial ( Sunitinib Trial in Adjuvant Renal Cancer), a Phase 3 study of SUTENT versus placebo in the adjuvant setting, met its primary endpoint of...
Why study charts? Because charts are like the footprints at the scene of the crime, clues to what the big money managers are likely thinking, Cramer says.
A call with investors Wednesday highlights drugs in the pipeline that could be attractive to bidders that reportedly include Sanofi, Pfizer and Celgene, among others.
The charts look favorable for these six high-yield dividend stocks. The stocks are among Deutsche Bank's list of best long ideas.
Pfizer, Merck and GlaxoSmithKline are all producing blockbuster vaccines and have others in their pipelines.
The company's shares were up nearly 2% in after hours trading.
Merck KGaA, Darmstadt, Germany, and Pfizer (NYSE: PFE) today announced the initiation of a Phase III study, JAVELIN Ovarian 100, to evaluate the efficacy and safety of avelumab* in combination with, and/or as follow-on...
There are renewed worries about Brexit as the British pound has fallen to a new 30 year low.
The biopharmaceutical company has entered into confidentiality agreements with Sanofi and others.
Following Brexit volatility, Deutsche Bank offered investors 42 best long ideas; here's the 12 stocks from the list with the highest dividend yields.
Pfizer is setting up well for a fresh rally leg that will likely carry the stock back up to the 2015 peak.
The second quarter comes to a close today and the real theme of the past three months is that oil controlled the direction of the stock market.
A breakdown below $33 would mean sellers have gained the upper hand.